# Hongyang Lu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hongyang-lu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,521 |
| Field | Lung Cancer Research Studies |
| h-index | 23 |
| i10-index | 43 |
| Last Known Institution | Zhejiang Cancer Hospital |
| OpenAlex ID | https://openalex.org/A5024914461 |
| ORCID iD | 0000-0003-0404-5153 |
| Works | 123 |

## Researcher papers

- [Adenosquamous carcinoma of the lung](https://scholariq.org/papers/adenosquamous-carcinoma-of-the-lung/)
- [H<sub>2</sub>S‐Releasing Versatile Montmorillonite Nanoformulation Trilogically Renovates the Gut Microenvironment for Inflammatory Bowel Disease Modulation](https://scholariq.org/papers/h-sub-2-sub-s-releasing-versatile-montmorillonite-nanoformulation-trilogically/)
- [Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer](https://scholariq.org/papers/cell-cycle-and-dna-damage-response-pathway-is-involved-in-leptomeningeal/)
- [Combined small-cell lung carcinoma](https://scholariq.org/papers/combined-small-cell-lung-carcinoma/)
- [Regional Differences in Agricultural Carbon Emissions in China: Measurement, Decomposition, and Influencing Factors](https://scholariq.org/papers/regional-differences-in-agricultural-carbon-emissions-in-china-measurement/)
- [Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study](https://scholariq.org/papers/apatinib-in-patients-with-extensive-stage-small-cell-lung-cancer-after-second/)
- [Study of small-cell lung cancer cell-based sensor and its applications in chemotherapy effects rapid evaluation for anticancer drugs](https://scholariq.org/papers/study-of-small-cell-lung-cancer-cell-based-sensor-and-its-applications-in/)
- [Invasive mucinous adenocarcinoma of the lung](https://scholariq.org/papers/invasive-mucinous-adenocarcinoma-of-the-lung/)
- [Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases](https://scholariq.org/papers/effects-of-icotinib-with-and-without-radiation-therapy-on-patients-with-egfr/)
- [Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer](https://scholariq.org/papers/banxia-xiexin-decoction-is-effective-to-prevent-and-control-irinotecan-induced/)
- [The analysis of molecular classification of pulmonary neuroendocrine tumors and relationship between YAP1 and efficacy](https://scholariq.org/papers/the-analysis-of-molecular-classification-of-pulmonary-neuroendocrine-tumors-and/)

## Researcher topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Zhejiang Cancer Hospital](https://scholariq.org/institutions/zhejiang-cancer-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.